TARGANTA THERAPEUTICS

targanta-therapeutics-logo

Targanta Therapeutics a biopharmaceutical company focused on the development and commercialization of innovative antibiotics for serious infections treated or acquired in hospitals and other institutional settings.

#Financial #Website #More

TARGANTA THERAPEUTICS

Social Links:

Industry:
Biopharma Health Care Pharmaceutical

Founded:
2005-12-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.targanta.com

Total Employee:
51+

Status:
Active

Contact:
973 290 6000

Email Addresses:
[email protected]

Total Funding:
70 M USD

Technology used in webpage:
Google Maps LetsEncrypt SSL By Default IPv6 Cloudflare Hosting Cloudflare CDN Cloudflare Cloudflare DNS Cloudflare Network Error Logging Clicky


Stock Details


Company's stock symbol is NASDAQ:TARG

Investors List

seaflower-ventures_image

Seaflower Ventures

Seaflower Ventures investment in Series C - Targanta Therapeutics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series C - Targanta Therapeutics

canadian-medical-discoveries-fund_image

Canadian Medical Discoveries Fund

Canadian Medical Discoveries Fund investment in Series C - Targanta Therapeutics

brookside-capital_image

Brookside Capital

Brookside Capital investment in Series C - Targanta Therapeutics

skyline-ventures_image

Skyline Ventures

Skyline Ventures investment in Series C - Targanta Therapeutics

radius-ventures_image

Radius Ventures

Radius Ventures investment in Series C - Targanta Therapeutics

Official Site Inspections

http://www.targanta.com

  • Host name: 104.21.64.137
  • IP address: 104.21.64.137
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Targanta Therapeutics"

Targanta Therapeutics - Corporate Overview

Targanta, Inc. is a biopharmaceutical company focused on developing and commercializing antibacterial agents. Targanta's latest-stage antibacterial drug, oritavancin, is a semisynthetic โ€ฆSee details»

Targanta Therapeutics Corporation - Wikipedia

Targanta Therapeutics Corporation was a biopharmaceutical company headquartered in Cambridge, Massachusetts. The company also had operations in Indianapolis, Montreal and Toronto. Targanta completed its initial public offering on October 9, 2007 and traded on the Nasdaq market under the symbol: TARG. Targanta was acquired by The Medicines Company in 2009. See details»

Targanta Therapeutics - Crunchbase Company Profile โ€ฆ

Targanta Therapeutics a biopharmaceutical company focused on the development and commercialization of innovative antibiotics for serious โ€ฆSee details»

Targanta Therapeutics - Corporate Mission

Homepage About Us. Corporate Mission; Corporate Overview; Compliance Program; Code of Conduct; Pipeline News People Careers Contact Us : Corporate Mission Targanta โ€ฆSee details»

Targanta Therapeutics - The Org

Targanta Therapeutics a biopharmaceutical company focused on the development and commercialization of innovative antibiotics for serious infections treated or acquired in hospitals and other institutional settings. Industries. โ€ฆSee details»

Targanta Therapeutics Corp. - Drug pipelines, Patents, Clinical โ€ฆ

Explore Targanta Therapeutics Corp. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 9 news, and 9 literature, Disease Domain ...See details»

Targanta Therapeutics Corporation - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Targanta Therapeutics Corporation of Parsippany, NJ. Get the latest business insights from Dun & โ€ฆSee details»

Targanta Therapeutics - Funding, Financials, Valuation & Investors

Targanta Therapeutics is registered under the ticker NASDAQ:TARG . Their stock opened with $10.00 in its Oct 10, 2007 IPO. Stock Symbol NASDAQ:TARG ; Money Raised at IPO $57.5M; โ€ฆSee details»

Targanta Therapeutics - PitchBook

Targanta Therapeutics was acquired on 26-Feb-2009. Who acquired Targanta Therapeutics? Targanta Therapeutics was acquired by The Medicines Company. Data Transparency. Meet โ€ฆSee details»

Board of Directors | The Medicines Company - targanta.com

Melvin K. Spigelman has been a director since September 2005. Since January 2009, Dr. Spigelman has served as president and chief executive officer of the Global Alliance for TB โ€ฆSee details»

Organization | Targanta

Targanta Report issue. Contributed to NME For profit Phase 2. Founded: Cambridge MA United States (1997) Status: Acquired by The Medicines Company (2009 ...See details»

Targanta Therapeutics - Overview, News & Similar companies

Jul 18, 2022 Who is Targanta Therapeutics. Targanta Therapeutics Corporation is a biopharmaceutical company focused on developing and commercializing innovative antibiotics โ€ฆSee details»

Targanta Therapeutics Corporation | OSC

B. Targanta Therapeutics (Ontario) Inc. ("Targanta Ontario"), a corporation incorporated under the CBCA on December 22, 2005 with a head office in Toronto, Ontario (Targanta Ontario and โ€ฆSee details»

Targanta Therapeutics - Contacts, Employees, Board Members

Targanta Therapeutics is a biopharma Company. AI Content may contain mistakes and is not legal, financial or investment advice.See details»

Corporate Governance | The Medicines Company - targanta.com

Sound corporate governance principles are the foundation of investor confidence and trust. These principles are critical to maintaining The Medicines Companyโ€™s reputation as a company โ€ฆSee details»

Targanta Therapeutics: Hitting a Moving Target - Case - Faculty ...

This case explores regulatory, product testing, and business strategy at Targanta Therapeutics, a biotech company preparing its first new drug application to the FDA. In October 2007, Mark โ€ฆSee details»

What is Targanta? Company Culture, Mission, Values

See what employees say it's like to work at Targanta. Salaries, reviews, and more - all posted by employees working at Targanta.See details»

Targenta - Main Page

[email protected] +358 41 7288443 Leija Yrityskeskus, Elannontie 3, 01510, Vantaa, FinlandSee details»

Targanta Therapeutics - Corporate Overview

Targanta's latest-stage antibacterial drug, oritavancin, is a semisynthetic glycopeptide with potent bactericidal activity against nearly all clinically relevant, difficult-to-treat Gram-positive โ€ฆSee details»

linkstock.net © 2022. All rights reserved